VIE/DEMA (VIE/DEMA)

Vienna Stock Exchange: VIE/DEMA · EUR

€48.6

+0.54 (+1.1%)· Recorded snapshot

Market cap	10.2B
Revenue (ttm)	3.3B
Net income (ttm)	215.9M
EPS (ttm)	€1.02
P/E (trailing)	47.5x
P/E (forward)	23.2x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.3B
Net income (ttm): 215.9M
EPS (ttm): €1.02
P/E (trailing): 47.5x
P/E (forward): 23.2x
Market cap: 10.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E23.2

P25 n/aP50 n/aP75 n/a

Trailing P/E47.5

P25 n/aP50 n/aP75 n/a

ROE23.3

P25 n/aP50 n/aP75 n/a

ROIC10.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/DEMA indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

DKK

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Denmark
Country code	AT
Earnings date	2026-11-06
Employees	26,616
Employees change	-88
Employees growth	-0.33%
Enterprise value	EUR 12.8B
Exchange	Vienna Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1904
Industry	Medical Devices
Is primary listing	No
ISIN number	DK0060738599
Last earnings date	2026-08-11
Last refreshed	2026-10-29
Market cap	EUR 10.2B
Next earnings date	2026-11-06
Price	EUR 48.56
Price currency	EUR
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-28
Symbol	vie/DEMA
Website	https://www.demant.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	30.65x
Average P/E ratio (3Y)	28.69x
Average P/E ratio (5Y)	28.47x
Earnings yield	2.11%
EV/Earnings	59.12x
EV/EBIT	22.34x
EV/EBITDA	16.43x
EV/FCF	28.69x
EV/Sales	3.87x
FCF / EV yield	3.49%
FCF yield	4.34%
Forward P/E	23.21x
Graham number	12.86004
Graham upside	-73.52%
Lynch fair value	EUR 5.12
Lynch upside	-89.46%
P/B ratio	6.76x
P/E ratio	47.5x
P/FCF ratio	23.02x
P/OCF ratio	19.54x
P/S ratio	3.11x
Price/EBITDA ratio	15.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	17.2%
EBITDA margin	20.19%
Effective tax rate	23.76%
FCF margin	13.5%
Gross margin	76.25%
Operating margin	17.2%
Pretax margin	12.9%
Profit margin	6.55%
Profit per employee	EUR 8,111
Profitable quarters	49
Profitable years	24
Revenue per employee	EUR 123,780
ROA	7.29%
ROA (5Y)	8.21%
ROCE	15.35%
ROE	23.3%
ROE (5Y)	29.41%
ROIC	10.73%
ROIC (5Y)	13.61%
Tax / revenue	3.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-29.26%
EPS growth (Q)	6.44%
EPS growth (QoQ)	178.01%
EPS growth 10Y	3.98%
EPS growth 3Y	1.92%
EPS growth 5Y	-3.47%
EPS growth quarters	1
EPS growth years	0
FCF growth	-11.89%
FCF growth (Q)	0.42%
FCF growth (QoQ)	-43.33%
FCF growth 3Y	6.66%
FCF growth 5Y	2.59%
Gross profit growth	9.66%
Gross profit growth (Q)	16.51%
Gross profit growth 3Y	6.38%
Gross profit growth 5Y	8.56%
Net income growth	-29.98%
Net income growth (Q)	6.18%
Net income growth (QoQ)	177.1%
Net income growth 3Y	0%
Net income growth 5Y	-5.8%
Net income growth quarters	1
Net income growth years	0
OCF growth	-10.59%
OCF growth (Q)	-3.63%
OCF growth (QoQ)	-40.47%
OCF growth 10Y	9.61%
OCF growth 3Y	4.97%
OCF growth 5Y	2.86%
Operating income growth	1.22%
Operating income growth (Q)	14.42%
Operating income growth 3Y	4.62%
Operating income growth 5Y	8.2%
Revenue growth	9.06%
Revenue growth (Q)	14.75%
Revenue growth (QoQ)	10.2%
Revenue growth 10Y	7.98%
Revenue growth 3Y	5.62%
Revenue growth 5Y	7.53%
Revenue growth quarters	3
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -79.2M
Depreciation and amortization	EUR 98.3M
EBIT	EUR 566.7M
EBITDA	EUR 665M
EPS	EUR 1.02
Financing cash flow	EUR 329.3M
Free cash flow	EUR 444.9M
Gross profit	EUR 2.5B
Income taxes	EUR 101M
Investing cash flow	EUR -807.2M
Net borrowing	EUR 329.6M
Net cash flow	EUR 47.3M
Net income	EUR 215.9M
Operating income	EUR 566.7M
Revenue	EUR 3.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.31
Book value per share	EUR 7.12
Debt / EBITDA	3.51
Debt / equity	1.79
Debt / FCF	6.1
Goodwill	EUR 2.6B
Interest coverage	7.82
Long-term assets	EUR 4B
Long-term liabilities	EUR 2.2B
Net cash (debt)	EUR -2.5B
Net cash / market cap	-24.54%
Net debt / EBITDA	3.78
Net debt / equity	1.66
Net debt / FCF	5.65
Piotroski F-Score	6
Property, plant and equipment	EUR 860.5M
Shareholders' equity	EUR 1.5B
Tangible book value	EUR -1.3B
Tangible book value per share	EUR -5.98
Total assets	EUR 5.4B
Total cash	EUR 200.1M
Total debt	EUR 2.7B
Total liabilities	EUR 3.8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.68
Current assets	EUR 1.4B
Current liabilities	EUR 1.7B
Current ratio	0.82
Inventory turnover	2.19
Net working capital	EUR 460.1M
Quick ratio	0.53
Working capital	EUR -296.9M
Working capital turnover	3.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.1%
Shareholder yield	1.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 36.16
1D price change	1.12%
1M price change	17.98%
1M total return	17.98%
1W price change	0.66%
1W total return	0.66%
1Y price change	58.18%
1Y return CAGR	58.23%
1Y total return	58.18%
20-day SMA	EUR 45.90
200-day SMA	EUR 33.67
3M price change	30.47%
3M total return	30.47%
3Y price change	37.76%
3Y return CAGR	11.27%
3Y total return	37.76%
50-day SMA	EUR 42.11
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 49.00
52-week high date	2026-10-28
52-week low	EUR 23.50
52-week low date	2026-02-12
5Y price change	18.12%
5Y return CAGR	3.39%
5Y total return	18.12%
6M price change	78.14%
6M total return	78.14%
All-time high	EUR 52.44
All-time high date	2021-08-04
All-time low	EUR 23.42
All-time low date	2022-11-03
Average true range (ATR)	EUR 0.79
Average volume	12.2
Change from 52-week high	-0.9%
Change from 52-week low	106.64%
Change from all-time high	-7.4%
Change from all-time low	107.34%
Change from open	0.75%
Day's gap	0.37%
High price	EUR 49.00
Low price	EUR 48.20
Monthly RSI	70.97
Open price	EUR 48.20
Position in 52-week range	45%
Previous close	EUR 48.02
Price vs 150-day SMA	34.29%
Price vs 20-day SMA	5.79%
Price vs 200-day SMA	44.22%
Price vs 50-day SMA	15.32%
Relative volume	19.43
RSI	70.99
Sharpe ratio	1.47
Sharpe ratio (3Y)	0.32
Sharpe ratio (5Y)	0.18
Sortino ratio	2.48
Sortino ratio (3Y)	0.62
Sortino ratio (5Y)	0.4
Weekly RSI	82.7
YTD price change	69.79%
YTD total return	69.79%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	83.8M
Shares change (QoQ)	-0.02%
Shares change (YoY)	-1.1%
Shares held by insiders	0.47%
Shares held by institutions	70.22%

Deeper analysis on VIE/DEMA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/DEMA report

Is a complete VIE/DEMA research report available?

No complete published report is available for vie/DEMA (VIE/DEMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/DEMA (VIE/DEMA)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/DEMA

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/DEMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/DEMA

Frequently asked questions